Cromos Pharma, where the patients are

Articles Published in 2014

Report: Healthcare M&As led by IT deals

Thursday, April 17, 2014 02:31 PM

The outlook for mergers and acquisitions in the healthcare/pharmaceutical information technology industry remains strong despite fewer transactions in 2013. But a broader mix of acquirers is looking to purchase companies that can improve clinical outcomes while reducing expenditures, according to a white paper from investment banker BerkeryNoyes.

More... »

CRF Health eCOA webinar series

ePharmaSolutions' ReferralPlus increases match rate for trial volunteers

Thursday, April 17, 2014 11:22 AM

ePharmaSolutions, a provider of eClinical solutions, says results of initial pilot studies for its patient matching and triaging solution, ReferralPlus, show a significant improvement in match rates for people actively searching for clinical trials in which to participate.

More... »


Drug developers use new models and methods to boost clinical success rates

Thursday, April 17, 2014 11:21 AM

Drug companies and their development partners seeking to increase clinical trial success rates of new drug candidates are developing tools to help them predict the likelihood of marketing approval and incorporating business planning earlier in clinical development, according to R&D leaders who recently participated in a roundtable discussion convened by the Tufts Center for the Study of Drug Development (CSDD).

More... »

Report: Anti-counterfeit packaging market to reach $142.7B by 2020

Thursday, April 17, 2014 11:20 AM

According to a new report by Allied Market Research titled Anti-counterfeit Packaging Market in Food and Pharmaceuticals—Technologies, Applications and Global Forecast through 2020, the global anti-counterfeit packaging market in food and pharmaceuticals is forecast to attain market value of $142.7 billion by 2020, from $57.4 billion in 2013, growing at 13.9% CAGR from 2013 to 2020. Technological advancements and government initiatives to curb counterfeiting is expected to drive the market growth.

More... »

Triclinium, Acquipharma collaborate to grow Africa’s clinical research

Thursday, April 17, 2014 11:18 AM

Triclinium Clinical Research, Africa’s largest independent niche CRO, and holding company Acquipharma, have merged to extend clinical research and development business activities in sub-Saharan Africa and other emerging markets. Under the shared umbrella of Acquipharma, Triclinium will collaborate with Cytespace Africa, a Pretoria-based site solutions organization (SSO).

More... »

NHS England approves $13.5M in funding for hepatitis C drug

Thursday, April 17, 2014 11:16 AM

NHS England has approved a $13.5 million investment in Sofosbuvir for the treatment of hepatitis C. About 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Gilead Sciences’ new drug.

More... »

Theorem Clinical Research, Medidata Solutions expand partnership

Thursday, April 17, 2014 11:15 AM

CRO Theorem Clinical Research recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud. Medidata Solutions is a global provider of cloud-based solutions for clinical research in life sciences.

More... »

Kineta, RLB Holdings form joint venture for high-need therapeutics

Wednesday, April 16, 2014 01:43 PM

Kineta, a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs.

More... »

Bio-Techne to acquire Shanghai PrimeGene Bio-Tech

Wednesday, April 16, 2014 01:40 PM

Techne, a developer, manufacturer and seller of biotechnology products and clinical controls, has announced that its R&D systems China subsidiary, a specialty manufacturer of biological products, has entered into an agreement to acquire 100% of Shanghai PrimeGene Bio-Tech.

More... »

inVentiv Health Clinical hired by IntelliCell Biosciences for Osteoarthritis IND

Wednesday, April 16, 2014 01:39 PM

CRO inVentiv Health Clinical has been selected for an osteoarthritis Investigational New Drug application (IND) by regenerative medicine biotechnology company IntelliCell BioSciences. IntelliCell will be studying the use of adult autologous vascular cells from blood vessels in adipose tissue to treat osteoarthritis of the knee.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs